Literature DB >> 27385042

Dexmedetomidine and delirium in the ICU.

Matthew McLaughlin1, Paul E Marik1.   

Abstract

Entities:  

Year:  2016        PMID： 27385042      PMCID： PMC4916356          DOI： 10.21037/atm.2016.05.44

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  10 in total

Review 1.  Dexmedetomidine: A Review of Its Use for Sedation in the Intensive Care Setting.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

2.  Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials.

Authors:  Stephan M Jakob; Esko Ruokonen; R Michael Grounds; Toni Sarapohja; Chris Garratt; Stuart J Pocock; J Raymond Bratty; Jukka Takala
Journal:  JAMA       Date:  2012-03-21       Impact factor: 56.272

3.  Delirium in critically ill patients: impact on long-term health-related quality of life and cognitive functioning.

Authors:  Mark van den Boogaard; Lisette Schoonhoven; Andrea W M Evers; Johannes G van der Hoeven; Theo van Achterberg; Peter Pickkers
Journal:  Crit Care Med       Date:  2012-01       Impact factor: 7.598

4.  Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU).

Authors:  E W Ely; S K Inouye; G R Bernard; S Gordon; J Francis; L May; B Truman; T Speroff; S Gautam; R Margolin; R P Hart; R Dittus
Journal:  JAMA       Date:  2001-12-05       Impact factor: 56.272

5.  Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit.

Authors:  E Wesley Ely; Ayumi Shintani; Brenda Truman; Theodore Speroff; Sharon M Gordon; Frank E Harrell; Sharon K Inouye; Gordon R Bernard; Robert S Dittus
Journal:  JAMA       Date:  2004-04-14       Impact factor: 56.272

6.  Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial.

Authors:  Valerie J Page; E Wesley Ely; Simon Gates; Xiao Bei Zhao; Timothy Alce; Ayumi Shintani; Jim Jackson; Gavin D Perkins; Daniel F McAuley
Journal:  Lancet Respir Med       Date:  2013-08-21       Impact factor: 30.700

7.  Effect of Dexmedetomidine Added to Standard Care on Ventilator-Free Time in Patients With Agitated Delirium: A Randomized Clinical Trial.

Authors:  Michael C Reade; Glenn M Eastwood; Rinaldo Bellomo; Michael Bailey; Andrew Bersten; Benjamin Cheung; Andrew Davies; Anthony Delaney; Angaj Ghosh; Frank van Haren; Nerina Harley; David Knight; Shay McGuiness; John Mulder; Steve O'Donoghue; Nicholas Simpson; Paul Young
Journal:  JAMA       Date:  2016-04-12       Impact factor: 56.272

8.  Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial.

Authors:  Pratik P Pandharipande; Brenda T Pun; Daniel L Herr; Mervyn Maze; Timothy D Girard; Russell R Miller; Ayumi K Shintani; Jennifer L Thompson; James C Jackson; Stephen A Deppen; Renee A Stiles; Robert S Dittus; Gordon R Bernard; E Wesley Ely
Journal:  JAMA       Date:  2007-12-12       Impact factor: 56.272

9.  Delirium in the ICU: an overview.

Authors:  Rodrigo Cavallazzi; Mohamed Saad; Paul E Marik
Journal:  Ann Intensive Care       Date:  2012-12-27       Impact factor: 6.925

10.  Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial.

Authors:  Michael C Reade; Kim O'Sullivan; Samantha Bates; Donna Goldsmith; William R S T J Ainslie; Rinaldo Bellomo
Journal:  Crit Care       Date:  2009-05-19       Impact factor: 9.097
  10 in total
  3 in total

1.  The safety of high-dose dexmedetomidine after cardiac surgery: a historical cohort study.

Authors:  Leo Leung; Lik Hang N Lee; Bobby Lee; Anthony Chau; Erica H Z Wang
Journal:  Can J Anaesth       Date:  2021-12-29       Impact factor: 6.713

2.  Dexmedetomidine-induced deep sedation mimics non-rapid eye movement stage 3 sleep: large-scale validation using machine learning.

Authors:  Sowmya M Ramaswamy; Maud A S Weerink; Michel M R F Struys; Sunil B Nagaraj
Journal:  Sleep       Date:  2021-02-12       Impact factor: 5.849

Review 3.  End-of-life care in patients with a highly transmissible respiratory virus: implications for COVID-19.

Authors:  Miriam Mottiar; Ariel Hendin; Lisa Fischer; Amanda Roze des Ordons; Michael Hartwick
Journal:  Can J Anaesth       Date:  2020-05-11       Impact factor: 6.713
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.